Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice

✍ Scribed by Yusuke Moritoh; Koji Takeuchi; Tomoko Asakawa; Osamu Kataoka; Hiroyuki Odaka

• Book ID: 113587604
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 808 KB
• Volume: 588
• Category: Article
• ISSN: 0014-2999
• DOI: 10.1016/j.ejphar.2008.04.018